Search by Drug Name or NDC
NDC 65862-0287-01 Perindopril Erbumine 4 mg/1 Details
Perindopril Erbumine 4 mg/1
Perindopril Erbumine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is PERINDOPRIL ERBUMINE.
MedlinePlus Drug Summary
Perindopril is used alone or in combination with other medications to treat high blood pressure. Perindopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It makes blood flow more smoothly by preventing the production of certain natural chemicals that tighten the blood vessels. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 65862-0287-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Perindopril
Product Information
| NDC | 65862-0287 |
|---|---|
| Product ID | 65862-287_00bc1834-9626-49a2-8727-7c976679635e |
| Associated GPIs | 36100035100320 |
| GCN Sequence Number | 033722 |
| GCN Sequence Number Description | perindopril erbumine TABLET 4 MG ORAL |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 13759 |
| HICL Sequence Number | 013911 |
| HICL Sequence Number Description | PERINDOPRIL ERBUMINE |
| Brand/Generic | Generic |
| Proprietary Name | Perindopril Erbumine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Perindopril Erbumine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | PERINDOPRIL ERBUMINE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA079070 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65862-0287-01 (65862028701)
| NDC Package Code | 65862-287-01 |
|---|---|
| Billing NDC | 65862028701 |
| Package | 100 TABLET in 1 BOTTLE (65862-287-01) |
| Marketing Start Date | 2009-11-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.43536 |
| Pricing Unit | EA |
| Effective Date | 2023-04-19 |
| NDC Description | PERINDOPRIL ERBUMINE 4 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |